Brain Interstitium Temozolomide Concentration Pre and Post Regadenoson Administration
Clinical trial NCT02389738 · COMPLETED
Trial details
- NCT number
- NCT02389738
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.